Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation

Stereotactic Body Radiation Therapy for Cholangiocarcinoma: Optimizing Locoregional Control With Elective Nodal Irradiation

Purpose: To review our institutional experience of treating cholangiocarcinoma using stereotactic body radiation therapy (SBRT). Methods and Materials: A total of 40 patients with intrahepatic (n = 25) or perihilar (n = 15) cholangiocarcinoma treated with SBRT were retrospectively reviewed. SBRT was...

Full description

Bibliographic Details
Main Authors:	Margaret M. Kozak, MD, Diego A.S. Toesca, MD, Rie von Eyben, MS, Erqi L. Pollom, MD, MS, Daniel T. Chang, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109419301149

Similar Items

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
by: Amanda J. Koong, et al.
Published: (2017-01-01)

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity
by: Diego A.S. Toesca, MD, et al.
Published: (2018-10-01)

Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 3 Trial
by: Orane Lorton, MS Dipl Ing, et al.
Published: (2023-11-01)

Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?
by: Patrick J. Sweigert, MD, et al.
Published: (2020-07-01)

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?
by: Penny Fang, MD, MBA, et al.
Published: (2024-12-01)

Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
by: Michael D. Schad, BS, et al.
Published: (2019-04-01)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
by: Kiri A. Sandler, MD, et al.
Published: (2016-10-01)

Stereotactic radiotherapy of radiation-induced meningioma previously irradiated retrobulbar for Graves' ophthalmopathy: A case report
by: Nao Tachizawa, MD, et al.
Published: (2024-03-01)

Early Tolerance Outcomes of Stereotactic Hypofractionated Accelerated Radiation Therapy Concomitant with Pelvic Node Irradiation in High-risk Prostate Cancer
by: Attapol Pinitpatcharalert, MD, et al.
Published: (2019-04-01)

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer
by: Cox James D, et al.
Published: (2009-01-01)

Clinical Outcomes Using Magnetic Resonance–Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma
by: Elaine Luterstein, BS, et al.
Published: (2020-03-01)

Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
by: Conor D. J. O’Donnell, et al.
Published: (2025-01-01)

Interventional Radiology Locoregional Therapies for Intrahepatic Cholangiocarcinoma
by: Gregory Woodhead, et al.
Published: (2024-02-01)

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
by: Michael J. LaRiviere, MD, et al.
Published: (2021-07-01)

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation
by: Jonathan W. Lischalk, et al.
Published: (2024-02-01)

Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
by: Laurel B. Darragh, et al.
Published: (2022-11-01)

Networking and Applying to Radiation Oncology During A Pandemic: Cross-Sectional Survey of Medical Student Concerns
by: Erqi L. Pollom, MD MS, et al.
Published: (2021-05-01)

Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection
by: Xiaoqin Ji, et al.
Published: (2022-07-01)

Cost Comparison From a Patient Perspective for Intracranial Stereotactic Radiation Therapy
by: Rahul N. Prasad, MD, MBA, et al.
Published: (2022-01-01)

The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma
by: Abdullah Esmail, et al.
Published: (2024-07-01)

Effect of Radiation Schedule on Transportation-Related Carbon Emissions: A Case Study in Rectal Cancer
by: Melissa A. Frick, MD, et al.
Published: (2023-09-01)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
by: Jonathan E. Schoenhals, BS, et al.
Published: (2021-09-01)

Adjuvant treatment of meningioma with stereotactic radiation surgery and hypofractionated stereotactic radiation surgery: Patterns of care and survival in a large, hospital database
by: Ashley Albert, MD, et al.
Published: (2018-07-01)

Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy
by: Rachel M. Glicksman, et al.
Published: (2025-01-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
by: Jonathan W. Lischalk, MD, et al.
Published: (2022-05-01)

Author Correction: Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
by: Laurel B. Darragh, et al.
Published: (2024-10-01)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
by: Sai Duriseti, MD, PhD, et al.
Published: (2021-05-01)

Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy
by: Brady S. Laughlin, MD, et al.
Published: (2023-03-01)

Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control
by: Ezra Hahn, MD, et al.
Published: (2022-11-01)

Single and Multifraction Spine Stereotactic Body Radiation Therapy and the Risk of Radiation Induced Myelopathy
by: J. John Lucido, PhD, et al.
Published: (2022-11-01)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
by: Maria L. Sandoval, MD, MS, et al.
Published: (2023-05-01)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
by: Noah S. Kalman, MD, MBA, et al.
Published: (2018-10-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
by: Pierre-Marie Pialat, MD, et al.
Published: (2021-07-01)

Echocardiographic Functional Outcomes Following Regional Nodal Irradiation for Breast Cancer Using Volumetric Modulated Arc Therapy
by: Anthony F. Yu, MD, MS, et al.
Published: (2024-10-01)

Brachial plexopathy after stereotactic body radiation therapy for apical lung cancer: Dosimetric analysis and preliminary clinical outcomes
by: Sumit S. Sood, MD, et al.
Published: (2018-01-01)

Reirradiation for Locoregional Recurrent Breast Cancer
by: Sayeh Fattahi, BS, et al.
Published: (2021-01-01)

Locoregional therapies in patients with recurrent intrahepatic cholangiocarcinoma after curative resection
by: Hsiao-Tien Liu, et al.
Published: (2020-12-01)

Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage
by: Mona Kamal, MD, PhD, et al.
Published: (2020-09-01)